Roger M. Perlmutter - 04 Feb 2026 Form 3 Insider Report for Eikon Therapeutics, Inc. (EIKN)

Reporting relationship: Chief Executive Officer and Director Exhibit List - Exhibit 24 - Power of Attorney, Director
Issuer ticker: EIKN
Reported as of: 04 Feb 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 04 Feb 2026, 21:21:16 UTC
Prior SEC filing: 08 Apr 2024
Next SEC filing: 10 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Benjamin Thorner, Attorney-in-Fact

Key filing fact

Roger M. Perlmutter filed Form 3 for Eikon Therapeutics, Inc. (EIKN) on 04 Feb 2026.

Key facts

This page summarizes Roger M. Perlmutter's Form 3 filing for Eikon Therapeutics, Inc. (EIKN).
0 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 04 Feb 2026, 21:21.

Change

Previous filing in this sequence was filed on 08 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001184228 Primary reporting owner

PERLMUTTER ROGER M

Relationship: Chief Executive Officer and Director Exhibit List - Exhibit 24 - Power of Attorney, Director
Address: C/O EIKON THERAPEUTICS, INC., 230 HARRIET TUBMAN WAY, MILLBRAE
Signature: /s/ Benjamin Thorner, Attorney-in-Fact
Signature date: 04 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EIKN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,190,999
Date: 04 Feb 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EIKN holding Derivative

Series A-1 Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 04 Feb 2026
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 170,143
Exercise price
Footnotes: F1, F2

EIKN holding Derivative

Series D Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 04 Feb 2026
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 114,714
Exercise price
Footnotes: F2, F3

EIKN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 04 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 869,981
Exercise price: $9.85
Footnotes: F4

EIKN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 04 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,608,481
Exercise price: $9.85
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Series A-1 Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Upon the closing of the Issuer's initial public offering ("IPO"), all shares of Series A-1 Preferred Stock will be converted into shares of Common Stock of the Issuer.

Footnote F2

The securities are held indirectly by the Reporting Person through Perlmutter Consulting, Inc. for the benefit of the Reporting Person. The Reporting Person has the sole pecuniary interest in the securities.

Footnote F3

The Series D Preferred Stock is convertible into Common Stock on a 1-for 7.4578 basis and has no expiration date. Upon the closing of the Issuer's IPO, all shares of Series D Preferred Stock will be converted into shares of Common Stock of the Issuer.

Footnote F4

The shares underlying the option will vest in equal monthly installments for four years after the vesting starting date, subject to the Reporting Person's continued service through each date.

SEC remarks

Chief Executive Officer and Director Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .